N

NeoGenomics(NEO)

FORT MYERS, FL
Diagnostics1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Genetic & Diagnostic Testing

NeoGenomics is a life sciences company focused on Genetic & Diagnostic Testing.

Rare Diseases
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
0

Pipeline & Clinical Trials

IO102-IO103 in combination with pembrolizumab
Lung Cancer Non Small Cell
Phase 2
Phase 2
Clinical Trials (1)
NCT05414032Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 1 clinical trial
Top TAs: Oncology
H-1B (2023): 1 approval
Publications: 25 in PubMed
SEC Filings: 2 available
Therapeutic Area Focus
Oncology
1 pipeline
Marketed
Pipeline

Financials (FY2025)

Revenue
$592M16%
R&D Spend
$27M(5%)10%
Net Income
-$88M
Cash
$367M
Source: SEC 10-K Filing

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 2 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub